The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
← catalyst calendarNCT04494295 · readout in 788 d
Sponsored by Integra LifeSciences Corporation (industry) · IART — their whole pipeline →. With Icahn School of Medicine at Mount Sinai, Oculus Imaging LLC.
Phase
—
Status
Recruiting
Study type
Observational
Enrollment
500estimated
Sites
20
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2020-10-23 | actual | When the study began enrolling |
| Primary completion | 2028-10-15 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2029-10-15 | estimated | The whole study's end, after follow-up |
| First posted | 2020-07-31 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-02-06 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Supratentorial Hemorrhage
Intervention
- Device: Aurora Surgiscope System
Primary outcome
what the primary-completion date above is the date OFRate of Surgical Success
measured During surgical procedure to evacuate supratentorial intracerebral hemorrhage
Permalink · IART's whole pipeline · Catalyst calendar · Every registered study · What changed